Inhalon Biopharma is a clinical-stage biotechnology company with a precedent-setting pulmonary drug delivery platform to treat patients suffering from acute respiratory infections, including respiratory syncytial virus (RSV), influenza, and SARS-CoV-2.
Address
North CarolinaUnited States